Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes and heart or blood vessel disease. This medicine is also used together with diet and exercise to help lose weight and keep the weight off in patients with obesity caused by certain conditions.
The global market for Semaglutide Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Semaglutide Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Semaglutide Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Semaglutide Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Semaglutide Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Semaglutide Injection players cover Novo Nordisk etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Semaglutide Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Semaglutide Injection market, with both quantitative and qualitative data, to help readers understand how the Semaglutide Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Semaglutide Injection market and forecasts the market size by Type (Dosage: 1.5ML and Dosage: 3 ML,), by Application (Hospitals and Clinics.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Dosage: 1.5ML
Dosage: 3 ML
Segmentation by application
Hospitals
Clinics
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Novo Nordisk
Chapter Introduction
Chapter 1: Scope of Semaglutide Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Semaglutide Injection market size (sales and revenue) and CAGR, Semaglutide Injection market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Semaglutide Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Semaglutide Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Semaglutide Injection market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Novo Nordisk. etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Semaglutide Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Semaglutide Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Semaglutide Injection by Country/Region, 2017, 2022 & 2028
2.2 Semaglutide Injection Segment by Type
2.2.1 Dosage: 1.5ML
2.2.2 Dosage: 3 ML
2.3 Semaglutide Injection Sales by Type
2.3.1 Global Semaglutide Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Semaglutide Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Semaglutide Injection Sale Price by Type (2017-2022)
2.4 Semaglutide Injection Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Semaglutide Injection Sales by Application
2.5.1 Global Semaglutide Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Semaglutide Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Semaglutide Injection Sale Price by Application (2017-2022)
3 Global Semaglutide Injection by Company
3.1 Global Semaglutide Injection Breakdown Data by Company
3.1.1 Global Semaglutide Injection Annual Sales by Company (2020-2022)
3.1.2 Global Semaglutide Injection Sales Market Share by Company (2020-2022)
3.2 Global Semaglutide Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Semaglutide Injection Revenue by Company (2020-2022)
3.2.2 Global Semaglutide Injection Revenue Market Share by Company (2020-2022)
3.3 Global Semaglutide Injection Sale Price by Company
3.4 Key Manufacturers Semaglutide Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Semaglutide Injection Product Location Distribution
3.4.2 Players Semaglutide Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Semaglutide Injection by Geographic Region
4.1 World Historic Semaglutide Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Semaglutide Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Semaglutide Injection Annual Revenue by Geographic Region
4.2 World Historic Semaglutide Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Semaglutide Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Semaglutide Injection Annual Revenue by Country/Region
4.3 Americas Semaglutide Injection Sales Growth
4.4 APAC Semaglutide Injection Sales Growth
4.5 Europe Semaglutide Injection Sales Growth
4.6 Middle East & Africa Semaglutide Injection Sales Growth
5 Americas
5.1 Americas Semaglutide Injection Sales by Country
5.1.1 Americas Semaglutide Injection Sales by Country (2017-2022)
5.1.2 Americas Semaglutide Injection Revenue by Country (2017-2022)
5.2 Americas Semaglutide Injection Sales by Type
5.3 Americas Semaglutide Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Semaglutide Injection Sales by Region
6.1.1 APAC Semaglutide Injection Sales by Region (2017-2022)
6.1.2 APAC Semaglutide Injection Revenue by Region (2017-2022)
6.2 APAC Semaglutide Injection Sales by Type
6.3 APAC Semaglutide Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Semaglutide Injection by Country
7.1.1 Europe Semaglutide Injection Sales by Country (2017-2022)
7.1.2 Europe Semaglutide Injection Revenue by Country (2017-2022)
7.2 Europe Semaglutide Injection Sales by Type
7.3 Europe Semaglutide Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Semaglutide Injection by Country
8.1.1 Middle East & Africa Semaglutide Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Semaglutide Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Semaglutide Injection Sales by Type
8.3 Middle East & Africa Semaglutide Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Semaglutide Injection
10.3 Manufacturing Process Analysis of Semaglutide Injection
10.4 Industry Chain Structure of Semaglutide Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Semaglutide Injection Distributors
11.3 Semaglutide Injection Customer
12 World Forecast Review for Semaglutide Injection by Geographic Region
12.1 Global Semaglutide Injection Market Size Forecast by Region
12.1.1 Global Semaglutide Injection Forecast by Region (2023-2028)
12.1.2 Global Semaglutide Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Semaglutide Injection Forecast by Type
12.7 Global Semaglutide Injection Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Semaglutide Injection Product Offered
13.1.3 Novo Nordisk Semaglutide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Semaglutide Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Semaglutide Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Dosage: 1.5ML
Table 4. Major Players of Dosage: 3 ML
Table 5. Global Semaglutide Injection Sales by Type (2017-2022) & (K Units)
Table 6. Global Semaglutide Injection Sales Market Share by Type (2017-2022)
Table 7. Global Semaglutide Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Semaglutide Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Semaglutide Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Semaglutide Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Semaglutide Injection Sales Market Share by Application (2017-2022)
Table 12. Global Semaglutide Injection Revenue by Application (2017-2022)
Table 13. Global Semaglutide Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Semaglutide Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Semaglutide Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Semaglutide Injection Sales Market Share by Company (2020-2022)
Table 17. Global Semaglutide Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Semaglutide Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Semaglutide Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Semaglutide Injection Producing Area Distribution and Sales Area
Table 21. Players Semaglutide Injection Products Offered
Table 22. Semaglutide Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Semaglutide Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Semaglutide Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Semaglutide Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Semaglutide Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Semaglutide Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Semaglutide Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Semaglutide Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Semaglutide Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Semaglutide Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Semaglutide Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Semaglutide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Semaglutide Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Semaglutide Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Semaglutide Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Semaglutide Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Semaglutide Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Semaglutide Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Semaglutide Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Semaglutide Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Semaglutide Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Semaglutide Injection Sales by Type (2017-2022) & (K Units)
Table 46. APAC Semaglutide Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Semaglutide Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Semaglutide Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Semaglutide Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Semaglutide Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Semaglutide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Semaglutide Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Semaglutide Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Semaglutide Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Semaglutide Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Semaglutide Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Semaglutide Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Semaglutide Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Semaglutide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Semaglutide Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Semaglutide Injection Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Semaglutide Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Semaglutide Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Semaglutide Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Semaglutide Injection
Table 66. Key Market Challenges & Risks of Semaglutide Injection
Table 67. Key Industry Trends of Semaglutide Injection
Table 68. Semaglutide Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Semaglutide Injection Distributors List
Table 71. Semaglutide Injection Customer List
Table 72. Global Semaglutide Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Semaglutide Injection Sales Market Forecast by Region
Table 74. Global Semaglutide Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Semaglutide Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Semaglutide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Semaglutide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Semaglutide Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Semaglutide Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Semaglutide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Semaglutide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Semaglutide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Semaglutide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Semaglutide Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Semaglutide Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Semaglutide Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Semaglutide Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Semaglutide Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Semaglutide Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Semaglutide Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Semaglutide Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novo Nordisk Basic Information, Semaglutide Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Novo Nordisk Semaglutide Injection Product Offered
Table 94. Novo Nordisk Semaglutide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Latest Developments
List of Figures
Figure 1. Picture of Semaglutide Injection
Figure 2. Semaglutide Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Semaglutide Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Semaglutide Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Semaglutide Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Dosage: 1.5ML
Figure 10. Product Picture of Dosage: 3 ML
Figure 11. Global Semaglutide Injection Sales Market Share by Type in 2021
Figure 12. Global Semaglutide Injection Revenue Market Share by Type (2017-2022)
Figure 13. Semaglutide Injection Consumed in Hospitals
Figure 14. Global Semaglutide Injection Market: Hospitals (2017-2022) & (K Units)
Figure 15. Semaglutide Injection Consumed in Clinics
Figure 16. Global Semaglutide Injection Market: Clinics (2017-2022) & (K Units)
Figure 17. Global Semaglutide Injection Sales Market Share by Application (2017-2022)
Figure 18. Global Semaglutide Injection Revenue Market Share by Application in 2021
Figure 19. Semaglutide Injection Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Semaglutide Injection Revenue Market Share by Company in 2021
Figure 21. Global Semaglutide Injection Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Semaglutide Injection Revenue Market Share by Geographic Region in 2021
Figure 23. Global Semaglutide Injection Sales Market Share by Region (2017-2022)
Figure 24. Global Semaglutide Injection Revenue Market Share by Country/Region in 2021
Figure 25. Americas Semaglutide Injection Sales 2017-2022 (K Units)
Figure 26. Americas Semaglutide Injection Revenue 2017-2022 ($ Millions)
Figure 27. APAC Semaglutide Injection Sales 2017-2022 (K Units)
Figure 28. APAC Semaglutide Injection Revenue 2017-2022 ($ Millions)
Figure 29. Europe Semaglutide Injection Sales 2017-2022 (K Units)
Figure 30. Europe Semaglutide Injection Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Semaglutide Injection Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Semaglutide Injection Revenue 2017-2022 ($ Millions)
Figure 33. Americas Semaglutide Injection Sales Market Share by Country in 2021
Figure 34. Americas Semaglutide Injection Revenue Market Share by Country in 2021
Figure 35. United States Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Semaglutide Injection Sales Market Share by Region in 2021
Figure 40. APAC Semaglutide Injection Revenue Market Share by Regions in 2021
Figure 41. China Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Semaglutide Injection Sales Market Share by Country in 2021
Figure 48. Europe Semaglutide Injection Revenue Market Share by Country in 2021
Figure 49. Germany Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Semaglutide Injection Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Semaglutide Injection Revenue Market Share by Country in 2021
Figure 56. Egypt Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Semaglutide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Semaglutide Injection in 2021
Figure 62. Manufacturing Process Analysis of Semaglutide Injection
Figure 63. Industry Chain Structure of Semaglutide Injection
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)